The Evolving Landscape of Second-Line Therapies in HCC Management onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ DelveInsight s Multiple Myeloma Market Insights report includes a comprehensive understanding of current treatment practices, multiple myeloma.
Dr Vidal expands on use of PI3K/AKT/mTOR pathway inhibitors following frontline progression, focusing on the PI3K inhibitor alpelisib for patients with PIK3CA mutations, as well as capivasertib, an AKT inhibitor in development.
Experts share how they approach management of patients with disease progression on first-line endocrine therapy, with a focus on ESR1 mutation testing and identifying who might be suitable for treatment with the oral SERD elacestrant.
HMP Global Announces Distinguished Faculty Lineup for Inaugural Great Debates & Updates in Women’s Oncology
Share Article
Program features clinical insight from prominent experts in the fields of gynecological and breast cancers; two-day agenda will address hot topics in an interactive, engaging format
“Delivered in the highly popular and uniquely interactive Great Debates & Updates format, this program will offer participants an engaging, educational opportunity,” said Kathleen N. Moore, MD, MS, and Conference Co-Chair of GDU Women’s Oncology. MALVERN, Pa. (PRWEB) April 14, 2021 HMP Global, a leading healthcare event and education company, today announced the agenda and faculty lineup for its inaugural Great Debates & Updates in Women’s Oncology, taking place online April 23-24 via the company’s VRTX virtual events platform. The meeting’s faculty is comprised of a distinguished lineup of accomplis